BETASERON Drug Profile
✉ Email this page to a colleague
Summary for Tradename: BETASERON
High Confidence Patents: | 5 |
Applicants: | 1 |
BLAs: | 1 |
Drug Prices: | Drug price information for BETASERON |
Recent Clinical Trials: | See clinical trials for BETASERON |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BETASERON |
Recent Clinical Trials for BETASERON
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Biogen | Phase 4 |
National Institutes of Health (NIH) | Phase 2 |
MediciNova | Phase 2 |
Recent Litigation for BETASERON
Identify key patents and potential future biosimilar entrants
PTAB Litigation
Petitioner | Date |
---|---|
Hopewell Pharma Ventures, Inc. et al. | 2023-02-10 |
Note on Biologic Patents
Matching patents to biologic drugs is far more complicated than for small-molecule drugs.
DrugPatentWatch employs three methods to identify biologic patents:
- Brand-side disclosures in response to biosimilar applications
- General brand-side disclosures
- Patents from broad patent text search
These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.
These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.
For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.
1) High Certainty: US Patents for BETASERON Derived from Brand-Side Litigation
No patents found based on brand-side litigation
2) High Certainty: US Patents for BETASERON Derived from Company Disclosures
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 4,450,103 | 2039-03-29 | Company disclosures |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 4,530,787 | 2004-03-28 | Company disclosures |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 4,588,585 | 2003-05-13 | Company disclosures |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 4,737,462 | 2005-04-12 | Company disclosures |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 4,959,314 | Company disclosures | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
3) Low Certainty: US Patents for BETASERON Derived from Patent Text Search
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 10,085,955 | 2033-01-08 | Patent claims search |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 10,233,171 | 2032-04-02 | Patent claims search |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 10,265,291 | 2035-07-15 | Patent claims search |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 10,273,252 | 2036-04-28 | Patent claims search |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 10,350,178 | 2033-01-08 | Patent claims search |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 10,428,382 | 2032-03-07 | Patent claims search |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 10,493,080 | 2031-02-18 | Patent claims search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
International Patents for BETASERON
Country | Patent Number | Estimated Expiration |
---|---|---|
Finland | 87233 | ⤷ Try for Free |
European Patent Office | 0200748 | ⤷ Try for Free |
Canada | 1233172 | ⤷ Try for Free |
New Zealand | 205922 | ⤷ Try for Free |
India | 161992 | ⤷ Try for Free |
Japan | S6128394 | ⤷ Try for Free |
United Kingdom | 8327490 | ⤷ Try for Free |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BETASERON
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
96C0019 | Belgium | ⤷ Try for Free | PRODUCT NAME: BETAFERON INTERFERON BETA-1B; REGISTRATION NO/DATE: EU/1/95/003/001 19951130 |
SPC/GB96/019 | United Kingdom | ⤷ Try for Free | |
SZ 10/1996 | Austria | ⤷ Try for Free | PRODUCT NAME: BETAFERON - INTERFERON BETA-1B |
>Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Beta Interferon Drugs Market: Understanding the Dynamics and Financial Trajectory of Betaseron
More… ↓